← Leaderboards
Philip Leighton
Origen Therapeutics
$441,665
Attributed
$441,665
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$441,665 · 2
By mechanism
R43$441,665 · 2
Top collaborators
No co-investigators on record.
Most similar at Origen Therapeutics
Same institution · by research overlap
- Marie-Cecile Van De Lavoir$2,588,521
- Babette S Heyer$3,115,895
- Lei Zhu$2,062,054
- Robert J Etches$114,172
Others in their field
Top investigators on “Immunologic Substance Development /Preparation”
- Maureen Howard · Chemocentryx, Inc.$7,605,790
- Israel Lowy · Medarex, Inc.$6,431,762
- Arthur M. Krieg · University Of Pennsylvania$6,250,700
- William C Olson · Progenics Pharmaceuticals, Inc.$5,661,660
- Vincent Strout · Elusys Therapeutics, Inc.$5,000,000
- Susan B Zolla-Pazner · New York University School Of Medicine$3,671,666
Research focus
Immunologic Substance Development /PreparationChickensGenetically Modified AnimalsHuman Genetic Material TagEgg /OvumEmbryonic Stem CellFusion GeneGene TargetingImmune ResponseImmunoglobulin GenesImmunoglobulin MNuclear TransferPassive ImmunizationAntibodyTransfectionAntibody FormationBioterrorism /Chemical WarfareB Lymphocyte